Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Govt extends deadline for submitting applications under PLI Scheme

Goa FDA issues advisory on 156 banned FDCs

Written By Ruchika Sharma19 Sept 2024 3:28 PM IST

Panaji: Following a recent ban on 156 fixed-dose combinations by the Central Government, the Directorate of Food and Drugs...

USFDA nod to Caplin Steriles Linezolid Injection to treat serious bacterial infections

Lupin bags USFDA nod for Bumetanide Injection for edema treatment

Written By Ruchika Sharma19 Sept 2024 11:30 AM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....

Novartis to Acquire Excellergy in USD 2 Billion Deal to Boost Food Allergy Pipeline

USFDA approves Novartis Kisqali to reduce risk of recurrence in people with HR+/HER2- early breast cancer

Written By Ruchika Sharma18 Sept 2024 3:04 PM IST

Basel: Novartis has announced that the US Food and Drug Administration (FDA) has approved Kisqali (ribociclib) in combination with an aromatase...

Wockhardt Chairman Dr Habil Khorakiwala conferred with BIRAC Innovator Award 2024

Written By Ruchika Sharma18 Sept 2024 1:07 PM IST

Mumbai: Biotechnology Industry Research Assistance Council (BIRAC), a Government of India enterprise, conferred the "BIRAC Innovator Award 2024" to...

Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe

Aurobindo Pharma arm AP facility gets EIR from USFDA

Written By Ruchika Sharma18 Sept 2024 11:30 AM IST

Hyderabad: Aurobindo Pharma has announced that the new injectable facility of Eugia Steriles Private Limited (a 100 percent subsidiary of...

Bal Krishan Saini designated as Senior Management Personnel of Panacea Biotec Pharma

DFC commits US$20 million long-term loan to Panacea Biotec towards capacity expansion project for Hexavalent Vaccine

Written By Ruchika Sharma17 Sept 2024 4:16 PM IST

New Delhi: The U.S. Government's development finance institution, the U.S. International Development Finance Corporation (DFC), has announced its...

Zydus Lifesciences pulled up by USFDA for manufacturing lapses at Gujarat plant

Written By Ruchika Sharma17 Sept 2024 12:33 PM IST

New Delhi: Zydus Lifesciences has been pulled up by the US health regulator for manufacturing lapses at its Gujarat-based plant.In a warning letter to...

After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug Nereus

Strides Pharma Science arm gets USFDA nod for Fluoxetine Tabs

Written By Ruchika Sharma16 Sept 2024 6:00 PM IST

Fluoxetine is an antidepressant of the Selective Serotonin Reuptake Inhibitor class.

Zydus Lifesciences arm inks pact with Viwit Pharma for two MRI Injectables

Written By Ruchika Sharma16 Sept 2024 12:45 PM IST

Zydus will exclusively market, distribute, and sell these products in the US market.

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

Laurus Labs Hyderabad facility successfully completes USFDA audit

Written By Ruchika Sharma16 Sept 2024 11:30 AM IST

Hyderabad: Laurus Labs Ltd., a research and development driven pharmaceutical and biotech company in India has announced the successful completion of...

DCGI suspends permission to Entod Pharma to manufacture, market PresVu, What next for the Company?

Written By Ruchika Sharma12 Sept 2024 3:06 PM IST

New Delhi: In response to the various alleged misleading claims made by Entod Pharma in respect to its Opthalmologic product, Drugs Controller General...

JnJ Tremfya receives USFDA approval for adults with moderately to severely active ulcerative colitis

Written By Ruchika Sharma12 Sept 2024 12:30 PM IST

Horsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved TREMFYA (guselkumab) for the treatment of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok